Trade Summary

2 months ago, Ra Capital Management, L.P., serving as Dir, 10% owner at Bicara Therapeutics Inc. (BCAX), purchased 300,000 shares at $16.00 per share, for a total transaction value of $4,800,000.00. Following this transaction, Ra Capital Management, L.P. now holds 7,255,993 shares of BCAX.

This purchase represents a 4.00% increase in Ra Capital Management, L.P.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, February 26, 2026 and publicly disclosed via SEC Form 4 filing on Monday, March 2, 2026, 4 days after the trade was made.

Bicara Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.